Evidence map›Paper›PMID 28744802›Full record

ArticleInternational orthopaedics2017

Survival of the Scandinavian total ankle replacement (STAR): results of ten to nineteen years follow-up.

Arno Frigg, Ursula Germann, Martin Huber, Monika Horisberger

Abstract read
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Talar component subsidence correlates with periprosthetic osteolysis after total ankle arthroplasty.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Effect of Total Ankle Arthroplasty and Ankle Arthrodesis for Ankle Osteoarthritis: A Comparative Study.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  13. Ankle Arthritis.Foot & ankle orthopaedics · 2019
    Review
  14. Observational
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arno FriggOrthopedic Department, University of Basel, Spitalstrasse 21, 4031, Basel, Switzerland. mail@arnofrigg.com.ORCID 0000-0001-9827-1199
Ursula GermannOrthopedic Department, University of Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Martin HuberFoot and Ankle Surgery Bern, Schänzlistrasse 33, 3013, Bern, Switzerland.
Monika HorisbergerOrthopedic Department, University of Basel, Spitalstrasse 21, 4031, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to evaluate survival and clinical outcome of the Scandinavian total ankle replacement (STAR) prosthesis after a minimum of ten years up to a maximum of 19 years.

methodsFifty STAR prostheses in 46 patients with end stage ankle osteoarthritis operated between 1996 and 2006 by the same surgeon (MH) were included. Minimal follow-up was ten years (median 14.6 years, 95% confidence interval [CI] 12.9-16.4). Clinical (Kofoed score) and radiological assessments were taken before the operation and at one, ten (+2), and 16 (±3) years after implantation. The primary endpoint was defined as exchange of the whole prosthesis or conversion to arthrodesis (def. 1), exchange of at least one metallic component (def. 2), or exchange of any component including the inlay (due to breakage or wear) (def. 3). Survival was estimated according to Kaplan-Meier. Further reoperations related to STAR were also recorded.

resultsThe ten year survival rate was (def. 1) 94% (CI 82-98%), (def. 2) 90% (CI, 77-96%), and (def. 3) 78% (CI 64-87%). The 19-year survival rate was (def. 1) 91% (CI 78-97%), (def. 2) 75% (CI 53-88%), and (def. 3) 55% (CI 34-71%). Considering any re-operations related to STAR, 52% (26/50) of prostheses were affected by re-operations. Mean pre-operative Kofoed score was 49, which improved to 84 after one year (n = 50), to 90 after ten years (n = 46), and to 89 after 16 years (n = 28).

conclusionsThe survival rate for def. 1 and 2 was high. However, re-operations occurred in 52% of all STAR prosthesis. STUDY

designRetrospective cohort study, evidence Level 4.

Indexed as

Prosthesis FailureAdultAgedAged, 80 and overAnkle JointArthrodesisArthroplasty, Replacement, AnkleCohort StudiesFemaleFollow-Up StudiesHumansJoint ProsthesisMaleMiddle AgedOsteoarthritisProsthesis DesignComplicationsRe-operationsStarSurvivalTotal ankle replacement

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.